Applications of graphene oxide in case of nanomedicines and nanocarriers for biomolecules: review study.
Graphene oxide
biomolecules
nanocarriers
nanomedicine
Journal
Drug metabolism reviews
ISSN: 1097-9883
Titre abrégé: Drug Metab Rev
Pays: England
ID NLM: 0322067
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
pubmed:
12
2
2019
medline:
31
12
2019
entrez:
12
2
2019
Statut:
ppublish
Résumé
In this Review article, recent progress in matter of graphene oxide (GO) synthesis and its functionalization via a vast range of materials, including small molecules, polymers, and biomolecules, were reported and systematically summarized in order to overcome the inherent drawbacks of GO nanocarriers and thereby make these nanocarriers suitable for delivering chemotherapeutic agents, genes, and short interfering RNAs. Briefly, this work describes current strategies for the large scale production of GO and modification of graphene-based nanocarriers surfaces through practical chemical approaches, improving their biocompatibility and declining their toxicity. It also describes the most relevant cases of study suitable to demonstrate the role of graphene and graphene derivatives (GD) as nanocarrier for anti-cancer drugs and genes (e.g. miRNAs). Moreover, the controlled release mechanisms within the cell compartments and blood pH for targeted therapeutics release in the acidic environment of tumor cells or in intracellular compartments are mentioned and explored.
Identifiants
pubmed: 30741033
doi: 10.1080/03602532.2018.1522328
doi:
Substances chimiques
Antineoplastic Agents
0
Drug Carriers
0
graphene oxide
0
Graphite
7782-42-5
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM